Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.

Vargo, John A

Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer. [electronic resource] - The Laryngoscope Jul 2014 - 1579-84 p. digital

Publication Type: Journal Article

1531-4995

10.1002/lary.24441 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Squamous Cell--diagnosis
Cetuximab
Combined Modality Therapy
Disease-Free Survival
ErbB Receptors
Female
Follow-Up Studies
Head and Neck Neoplasms--diagnosis
Humans
Incidence
Male
Middle Aged
Neoplasm Recurrence, Local--epidemiology
Neoplasm Staging
Quality of Life
Radiosurgery--methods
Radiotherapy Dosage
Radiotherapy, Adjuvant--methods
Retrospective Studies
Salvage Therapy--methods
Squamous Cell Carcinoma of Head and Neck
Survival Rate--trends
United States--epidemiology